Clinical Directors Meeting

1
Clinical Directors Meeting
Room 2, Friends House 173 Euston Road, London 1
November 2007
Peter Selby Joint Director
2
Clinical Directors Meeting

• Introduction
• Activities of last 3 months
• What is being done to support Clinical Directors?
• What Clinical Directors need to be doing?

3
Agenda

• Presentation Where we are now
• Discussion Topics
• Executive Group
• Provision of NHS Infrastructure Funding
• Allocation of sessional support
• Speciality Network Groups
• Convincing the NHS to engage fully
• What to you want the UKCRN CC and DH to do for
  you to make this work?
• Others

4
UKCRN Overall Aim

• To develop UK-wide infrastructure embedded within
  the NHS to support high quality research across
  all areas of health and clinical need funded by
  both commercial and non-commercial funders

5
Clinical Research Networks

• PURPOSE
• Benefits for Patients and Public--health --both
  through improving the process of care and new
  evidence for better care
• Excellence and Innovation in Clinical Research
• Links with Industrywealth

6
A Whole System
Network Infrastructure in the NHS
Industry Funders
Academic Funders
INDUSTRY FUNDERS
Patients
Portfolio- Clinical Studies Groups
Clinical Trials Units/ RDSUs/RDS
NATIONAL COORDINATING CENTRE(S)
7
(No Transcript)
8
Supporting Clinical Directors

• UKCRN Academic Directors
• Janet
• Paul
• Peter
• Two Deputy Directors TBA
• will each support 5 CLRN Directors
• Assistant Director Involvement

9
Local Research Networks
TOPIC CLINICAL RESEARCH NETWORKS
CANCER
STROKE
DIABETES
MEDICINES in CHILDREN
MENTAL HEALTH
DEMENTIA
UK Clinical Research Network (UKCRN)
10
(No Transcript)
11
PCRN Local Research Networks in England

• 8 LRNs
• Total population 50.4m (100 coverage)
• Over 49 (WTE) staff

12
TCRN Coordinating Centres
Professor Paul WallaceDeputy Director for
Primary Care
Professors Janet Darbyshire Peter SelbyUKCRN
and NIHR CCRN CC and PCRN
Professor Gary FordDirector, Stroke Research
Network
Professor David Cameron Director, National
Cancer Research Network
Professor Ros SmythDirector, Medicines for
Children Research Network
Professor Til WykesDirector, Mental Health
Research Network
Professors Martin Rossor and Ian
McKeithCo-Directors, Dementias and
Neurodegenerative Diseases Research Network
Professor Des JohnstonDirector, Diabetes
Research Network
13
UKCRN Coordinating Centre Workstreams

• Setting up Networks
• Research Management-central sign off, passports
  costings etc.
• Portfolio Definition
• Industry links
• Training and Education
• Research Governance/Advice
• Clinical Trials Units and research design support
• Information Systems
• Patient and Public Involvement
• Experimental Medicine
• Speciality Network Groups
• Communication

14
CLRN- A balance between national standards and
consistency and local ownership and control!

• Geography-functional clinical research
  entities(100)
• Host Organisations(100)
• Clinical Directors(100)
• Network Boards(100)
• Executive Groups (?)
• Network managers 64 / 68
• NHS Infrastructure(beginning-funded!)
• Portfolio
  definition
• Speciality
  Groups
• Done quickly and in parallelfor patients
• and staff (April October 2007)

15
(No Transcript)
16
Resources

• Year 1- Allocated to all networks asap
• Core team (5 posts) 300k pa per CLRN
• Per capita allocation (1.5M per 2M pop)
• Research management and governance
• Research Infrastructure staff (includes sessions
  for clinicians)
• In addition to existing transition funding and
  TCRN funding
• April 2008
• Additional activity based resources
• Increased operational staff and non-staff costs
• Rising to 90M pa any necessary increases
  thereafter

17
Work In Progress

• Speciality Network Groupssubject specific
  aspects of CCRN
• Developing new studiesClinical Studies Groups

18
Work In Progress

• Speciality Network Groupssubject specific
  aspects of CCRN
• Developing new studiesClinical Studies Groups

19
NHS INFRASTRUCTURE
INDUSTRY STUDIES
an example for Respiratory Health
Lead
Functions
INDUSTRY LINKS ADOPTION ADVICE FEASIBILITY.
Local
National
20
INDUSTRY STUDIES
NHS INFRASTRUCTURE
Local
National
PORTFOLIO GENERATION IN ACADEMIC SECTOR
Portfolio Development FUNDERS PROVIDE PRIORITIES
AND SUPPORT
Short Term Groups
21
UKCRC Health Research Categories
To be modified mainly by sub-divisions
Comments to Joanne Olliver J.Olliver_at_ukcrn.org.u
k
22
Work In Progress

• Network Groupssubject specific aspects of CCRN
• Developing new studiesClinical Studies Groups

23
Academic Funders

• The Arthritis Research Campaign
• New CSGs Chairs
• Rheumatoid Arthritis John Issacs, Newcastle
• Spondyloarthropathy Hill Gaston, Cambridge
• Autoimmune Rheumatoid
• Arthritis David Isenberg, UCL
• Osteoarthritis Phil Conaghan, Leeds
• Musculoskeletal Bone
• Disease David Reid, Aberdeen
• Pain Elaine Hay, Keele
• Childhood Arthritis Dr Michael Beresford,
  Liverpool

24

• Bureaucracy busting or Bureaucracy management

25
CLRN Directors and Teams

• Appointments managers etc.
• Executive Groups
• Estates/Finance/HR links to host organisations
• Areas of strength and development - identifying
• NHS Infrastructure and funding FIND
• FIT
• FUND
• Operational and management staff to
• - move to support Portfolio studies
• - in areas chosen
• - provide essential RM and G input
• - this year (and thereafter)
• - based on your judgement of needs and
  contributions
• PHARMACY
• IMAGING

26
Central Sign-Off (CSO)

• NHS acceptance
• NHS organisations are the key to delivering CSO
• CSO Unit (UKCRN CC) and CLRNs can
• - conduct excellent process
• - pay for all staff involved
• - deliver meticulous work in a timely way
• - be subject to independent audit
• BUT
• NHS organisations need to provide a signatory
  person promptly for system to work
• - 2 weeks
• - come rain or shine
• Requires confidence and communication
• Not all will wish to do so

27
Conclusions

• A wonderful research opportunity
• A large amount of change rapidly
• Broad support but an anxious research management
  community
• Could become the best whole system for clinical
  research in the world
• Bureaucratic limitations remain a real
  challenge-we can mend some things.
• All help and advice gratefully received

Janet and Peter
28

• Discussion Topics
• Executive Group
• Relationship between Board and Clinical Director
• Provision of NHS Infrastructure Funding
• Employment issues
• Allocation of sessional support
• Speciality Network Groups
• Activity based funding
• Clarifying costs (ARCO)
• Convincing the NHS to engage fully
• Relationship with TCRN/PCRNs
• Links innovation hubs
• Local adoption procesess
• What to you want the UKCRN CC and DH to do for
  you to make this work